Suppr超能文献

肥胖对肾脏的影响。

Renal consequences of obesity.

机构信息

Department of Nephrology and Transplantation with Dialysis Unit, Medical University, Bialystok, Poland.

出版信息

Med Sci Monit. 2010 Aug;16(8):RA163-70.

Abstract

The worldwide prevalence of obesity and its associated metabolic and cardiovascular disorders has risen dramatically within the past 2 decades. Our objective is to review the mechanisms that link obesity with altered kidney function. Current evidence suggests that excess weight gain may be responsible for 65-75% of the risk for arterial hypertension. Impaired renal pressure natriuresis, initially due to increased renal tubular sodium reabsorption, is a key factor linking obesity with hypertension. Obesity increases renal sodium reabsorption by activating the renin-angiotensin and sympathetic nervous systems, and by altering intrarenal physical forces. Adipose tissue functions as an endocrine organ, secreting hormones/cytokines (e.g., leptin) which may trigger sodium retention and hypertension. Additionally, excess visceral adipose tissue may physically compress the kidneys, increasing intrarenal pressures and tubular reabsorption. Eventually, sustained obesity via hyperinsulinemia, due to resistance to insulin, causes hyperfiltration, resulting in structural changes in the kidneys--glomerular hyperthrophy and occasionally focal segmental glomerulosclerosis. The consequences of kidney injury are continuous loss of glomerular filtration rate, further increase of arterial pressure and escalation of cardiovascular morbidity and mortality. There is a growing awareness of the renal consequences of obesity, and considerable progress is being made in understanding its pathophysiology. Weight reduction results in lowered proteinuria. Aside from low sodium diet and exercises, more widespread use of renoprotective therapy (e.g., ACE inhibitors and statins) in treatment of hypertension in obese subjects should be advocated. Renal protection should result in reducing the cardiovascular complications of obesity.

摘要

在过去的 20 年中,肥胖及其相关的代谢和心血管疾病在全球范围内的患病率急剧上升。我们的目标是回顾将肥胖与肾功能改变联系起来的机制。目前的证据表明,体重过度增加可能导致 65-75%的动脉高血压风险。最初由于肾小管钠重吸收增加而导致的肾脏压力排钠功能受损,是肥胖与高血压相关的一个关键因素。肥胖通过激活肾素-血管紧张素和交感神经系统,以及改变肾内物理力量,增加肾脏钠重吸收。脂肪组织作为内分泌器官,分泌激素/细胞因子(如瘦素),可能引发钠潴留和高血压。此外,过多的内脏脂肪组织可能会对肾脏造成物理压迫,增加肾内压力和肾小管重吸收。最终,由于对胰岛素的抵抗导致的高胰岛素血症会导致持续的肥胖,引起高滤过,导致肾脏结构改变——肾小球肥大,偶尔还会出现局灶节段性肾小球硬化。肾脏损伤的后果是肾小球滤过率持续下降,进一步增加动脉压,并使心血管发病率和死亡率上升。人们越来越意识到肥胖对肾脏的影响,并且在理解其病理生理学方面取得了相当大的进展。减轻体重会导致蛋白尿减少。除了低盐饮食和运动外,还应提倡在肥胖患者的高血压治疗中更广泛地使用肾保护治疗(如 ACE 抑制剂和他汀类药物)。肾脏保护应能降低肥胖的心血管并发症。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验